Abstract
Cancer cells are known to inactivate tumor suppressor proteins by triggering their anomalous subcellular location. It has been well established that the aberrant location of FOXO proteins is linked to tumor formation, progression of the same, or resistance to anti-neoplastic treatment. Furthermore, the abnormal location of FOXO has also been considered a potential biomarker for diabetic complications or longevity in different organisms. Here, we describe the immunodetection of endogenous FOXO by confocal microscopy, which can be used as a chemical tool to quantify FOXO expression levels, its cellular location, and even its active/inactive forms with relevant antibodies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Elias JM (1999) Immunohistochemistry: a brief historical perspective. J Histotechnol 22:163–167. https://doi.org/10.1179/his.1999.22.3.163
Lehtinen MK, Yuan Z, Boag PR et al (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125:987–1001. https://doi.org/10.1016/j.cell.2006.03.046
Liu P, Begley M, Michowski W et al (2014) Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508:541–545. https://doi.org/10.1038/nature13079
Hofman FM, Taylor CR (2001) Immunohistochemistry. Curr Protoc Immunol. https://doi.org/10.1002/0471142735.im2104s103
Yang J-Y, Zong CS, Xia W et al (2008) ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10:138–148
Duraiyan J, Govindarajan R, Kaliyappan K, Palanisamy M (2012) Applications of immunohistochemistry. J Pharm Bioallied Sci 4:S307–S309. https://doi.org/10.4103/0975-7406.100281
Blagosklonny MV (2012) Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI’s provocative questions. Oncotarget 3:1711–1724. https://doi.org/10.18632/oncotarget.890
Kau TR, Way JC, Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 4:106–117
Seoane J, Le H-V, Shen L, Anderson SA, Massagué J (2004) Integration of smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211–223. https://doi.org/10.1016/S0092-8674(04)00298-3
Garrett JT, Olivares MG, Rinehart C et al (2011) Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proc Natl Acad Sci 108:5021–5026. https://doi.org/10.1073/pnas.1016140108
Kau TR, Schroeder F, Ramaswamy S et al (2003) A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 4:463–476. https://doi.org/10.1016/S1535-6108(03)00303-9
Kitamura YI, Kitamura T, Kruse J-P et al (2005) FOXO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab 2:153–163. https://doi.org/10.1016/j.cmet.2005.08.004
Zanella F, dos Santos NR, Link W (2013) Moving to the core: spatiotemporal analysis of forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation. Traffic 14:247–258. https://doi.org/10.1111/tra.12034
Cautain B, Castillo F, Musso L et al (2016) Discovery of a novel, isothiazolonaphthoquinone-based small molecule activator of FOXO nuclear-cytoplasmic shuttling. PLoS One 11:e0167491
Calnan DR, Brunet A (2008) The FOXO code. Oncogene 27:2276–2288. https://doi.org/10.1038/onc.2008.21
Wang R, Yang S, Nie T et al (2017) Transcription factors: potential cell death markers in parkinson’s disease. Neurosci Bull 33(5):552–560. https://doi.org/10.1007/s12264-017-0168-4
Cyert MS (2001) Regulation of nuclear localization during signaling. J Biol Chem 276:20805–20808. https://doi.org/10.1074/jbc.R100012200
Martins R, Lithgow GJ, Link W (2016) Long live FOXO: unraveling the role of FOXO proteins in aging and longevity. Aging Cell 15:196–207. https://doi.org/10.1111/acel.12427
Terragni J, Graham JR, Adams KW et al (2008) Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFκB transcription factors. BMC Cell Biol 9:6. https://doi.org/10.1186/1471-2121-9-6
Van Der Heide LP, Hoekman MFM, Smidt MP (2004) The ins and outs of FOXO shuttling: mechanisms of FOXO translocation and transcriptional regulation. Biochem J 380:297–309. https://doi.org/10.1042/BJ20040167
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Castillo, F., Mackenzie, T.A., Cautain, B. (2019). Immunofluorescence Analysis by Confocal Microscopy for Detecting Endogenous FOXO. In: Link, W. (eds) FOXO Transcription Factors. Methods in Molecular Biology, vol 1890. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-8900-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8900-3_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-8899-0
Online ISBN: 978-1-4939-8900-3
eBook Packages: Springer Protocols